首页> 外文期刊>Journal of Rapid Methods and Automation in Microbiology >RAPID MULTIPLEX PCR ASSAY FOR SIMULTANEOUS DETECTION OF MAJOR ANTIBIOTIC RESISTANCE DETERMINANTS IN CLINICAL ISOLATES OF BACTEROIDES FRAGILIS
【24h】

RAPID MULTIPLEX PCR ASSAY FOR SIMULTANEOUS DETECTION OF MAJOR ANTIBIOTIC RESISTANCE DETERMINANTS IN CLINICAL ISOLATES OF BACTEROIDES FRAGILIS

机译:快速多重PCR检测可同时检测脆性杆菌的临床分离株中的主要抗药性决定因素

获取原文
获取原文并翻译 | 示例
           

摘要

ABSTRACTThis study developed a rapid and cost-effective multiplex polymerase chain reaction assay (M-PCR) for simultaneous detection of major clinically relevant antibiotic resistance genes inBacteroides fragilis. The M-PCR optimized amplification conditions with primers designed for detection of five resistance genes: carbapenems (cfiA) and cephalosporins(cepA), clindamycin (ermF), metronidazole (nimA-F) and tetracycline (tetQ), plus a set of primers for theB. fragilis 16S rRNA gene (positive control). An initial single PCR was performed for each gene, followed by a gradient PCR to determine the optimal PCR conditions for each primer set. This was followed by several test M-PCRs using the Qiagen multiplex PCR kit (Valencia, CA) with 60ng of a template DNA mastermix containing all genes of interest and 0.2 mu M of each primer set. Multiplex PCR products were detectable at annealing temperatures ranging from 53-57C for 30-35 cycles. The final optimized M-PCR was then used to evaluate 21 differentB. fragilis isolates from various patients. Eleven different M-PCR genotypes were obtained, which correlated with phenotypic antibiograms and nitrocefin beta -lactamase production assays. This M-PCR provides an accurate, rapid, sensitive and cost-effective tool for detecting clinically relevant antibiotic resistance genes inB. fragilis, and owing to its high sensitivity, it could also be used to investigate the prevalence of such genetic determinants in mixed bacterial specimens.PRACTICAL APPLICATIONSThe current study provides an easy and rapid method for detecting antibiotic resistance determinants in bacteria. This will in turn enhance treatment methods and development of novel therapeutic strategies.
机译:摘要这项研究开发了一种快速且经济高效的多重聚合酶链反应分析(M-PCR),用于同时检测脆弱拟杆菌中的主要临床相关抗生素抗性基因。 M-PCR优化了扩增条件,并设计了用于检测五个耐药基因的载体:碳青霉烯(cfiA)和头孢菌素(cepA),克林霉素(ermF),甲硝唑(nimA-F)和四环素(tetQ),以及用于B.脆弱的16S rRNA基因(阳性对照)。对每个基因进行初始单次PCR,然后进行梯度PCR,以确定每个引物组的最佳PCR条件。接下来是使用Qiagen多重PCR试剂盒(加利福尼亚州瓦伦西亚)进行的多个测试M-PCR,其中包含60ng模板DNA预混液,其中包含所有目的基因,每个引物对均为0.2μM。在53-57℃的退火温度下进行30-35个循环可以检测到多重PCR产物。然后将最终优化的M-PCR用于评估21种不同的B。脆弱类从各种患者中分离出来。获得了11种不同的M-PCR基因型,这些基因型与表型抗菌谱和硝化菌素β-内酰胺酶生产分析相关。该M-PCR提供了一种准确,快速,灵敏且具有成本效益的工具,可以检测B中与临床相关的抗生素抗性基因。脆弱类细菌,由于其高灵敏度,也可用于研究混合细菌标本中此类遗传决定因素的流行。这反过来将增强治疗方法并开发新的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号